IceCure Medical Expects Significant Q4 Sales Increase in North America

miércoles, 17 de diciembre de 2025, 8:33 am ET1 min de lectura
ICCM--

• IceCure Medical expects significant Q4 sales increase in North America • ProSense console and cryoprobes see surge in interest • FDA approved for low-risk breast cancer treatment in women over 70 • Installed at top US medical institutions • Preliminary data suggests record North American sales levels • IceCure Medical's minimally-invasive cryoablation technology destroys tumors by freezing.

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios